MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...

CD Genomics, a leading provider of genomic services, is excited to announce the launch of its PacBio Single Molecule, Real-Time (SMRT) Sequencing service. This cutting-edge technology is set to ...

MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms ...

In addition, a SMRT Link and instrument software upgrade paired with the release of SPRQ chemistry provides new DNA methylation callers that greatly increase the multiomics capabilities of every Revio ...

MENLO PARK, Calif. - PacBio (NASDAQ:PACB), a $486.6 million market cap biotechnology company, announced Tuesday a series of innovations for its Revio and Vega sequencing platforms that could reduce ...

MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its ...

PacBio (NASDAQ: PACB), announced the Vega™ system, the company’s first benchtop long-read sequencing platform. Vega delivers all the functionality of the Revio system, PacBio’s high-throughput ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued focus on research and development and a robust product portfolio. The optimism, led by a ...

MENLO PARK, Calif. - PacBio (NASDAQ: PACB), a company specializing in sequencing solutions, has introduced a new sequencing chemistry named SPRQ for its Revio long-read sequencing system. This ...